02287nim a2200541 a 4500
HST8228
UkLoHST
m o h
cr nna||||||||
sr |mnnnnnzne|
210704s2021 enk|||||o||h||||||||eng d
8228
Henry Stewart Talks
(UkLoHST)4675
UkLoHST
eng
UkLoHST
Crowe, James E.
spk
SARS-COV-2 human monoclonal antibody therapy update
[electronic resource] /
James E. Crowe.
London :
Henry Stewart Talks,
2021.
1 online resource (1 streaming audio file (11 min.)).
Interviews on Covid-19,
2056-452X
Audio interview.
Title from title frames.
Contents: Review of the research done since the start of the pandemic -- Current work covering the SARS-CoV-2 variants -- The selection process of monoclonal antibodies for development -- Next steps in the research and future strategies -- The AHEAD100 project i.e. generating neutralizing antibodies for the 100 most likely causes of future epidemics.
Access restricted to subscribers.
Mode of access: World Wide Web.
Antiviral agents
Development.
Coronavirus infections
Chemotherapy.
Coronavirus infections
Immunological aspects.
COVID-19 (Disease)
Research.
COVID-19 (Disease)
Treatment.
Drug development.
Monoclonal antibodies
Research.
Monoclonal antibodies
Therapeutic use.
Antibodies, Monoclonal
pharmacology.
Antibodies, Monoclonal
therapeutic use.
Antibodies, Neutralizing.
Antiviral Agents.
Betacoronavirus
drug effects.
COVID-19
drug therapy.
COVID-19
immunology.
Drug Discovery.
Immunotherapy.
Neutralization Tests.
Pandemics.
SARS-CoV-2
drug effects.
Henry Stewart talks.
Biomedical & life sciences collection.
Interviews on Covid-19.
https://hstalks.com/bs/4675/
https://hstalks.com/bs/p/1060/
Series
75734
75734